Patient and System Factors Associated With Completed Follow-Up of Probably Benign (BI-RADS 3) Breast Imaging Findings.


Journal

Journal of the American College of Radiology : JACR
ISSN: 1558-349X
Titre abrégé: J Am Coll Radiol
Pays: United States
ID NLM: 101190326

Informations de publication

Date de publication:
09 2023
Historique:
received: 25 11 2022
revised: 09 02 2023
accepted: 17 02 2023
medline: 23 10 2023
pubmed: 7 4 2023
entrez: 6 4 2023
Statut: ppublish

Résumé

Evaluate patient factors and health system test ordering and scheduling processes associated with completed BI-RADS 3 breast imaging follow-up. Retrospective review of reports from January 1, 2021, to July 31, 2021, identified BI-RADS 3 findings corresponding to unique patient encounters (index examinations). The electronic health record was queried for patient, examination, and health system ordering or scheduling data including follow-up order status (order placed, performed; order placed, scheduled, but not performed; order placed, unscheduled; no order placed); ordering provider specialty and health system affiliation (primary care versus other, internal versus external to health system); and ordering department (radiology staff versus referring physician staff). Patient home addresses were categorized by area deprivation index (University of Wisconsin's Neighborhood Atlas). Univariable and multivariable analysis identified patient, examination, and ordering or scheduling factors associated with completed follow-up imaging within 15 months of BI-RADS 3 assessment. There were 3,104 unique BI-RADS 3 assessments, 2,561 (82.5%) with completed BI-RADS 3 follow-up within 15 months of study examination. In multivariable analysis, factors associated with incomplete follow-up included ultrasound (odds ratio [OR] 0.48; 95% confidence interval [95% CI] 0.38-0.60; P < .001) and MRI (OR 0.71; 95% CI 0.50-1.00; P = .049) versus mammogram; patients living in the highest disadvantaged neighborhoods (OR 0.70; 95% CI 0.50-0.98; P = .04); patients <40 years (OR 0.14; 95% CI 0.11-0.19; P < .001); Asian race (OR 0.55; 95% CI 0.37-0.81; P = .003); order placement >3 months (OR, 0.05; 95% CI 0.02-0.16; P < .001) after index examination or scheduling >6 months after order placement (OR, 0.35; 95% CI 0.14-0.87; P = .02); order placement by breast oncology or breast surgery departments (OR 0.35; 95% CI 0.17-0.73; P = .01) versus radiology department. Incomplete BI-RADS 3 follow-up is associated with ultrasound or MRI, most socioeconomically disadvantaged patients, younger patients, Asian race, delayed order entry, and follow-up examination ordering and scheduling by non-radiology departments.

Identifiants

pubmed: 37023884
pii: S1546-1440(23)00268-5
doi: 10.1016/j.jacr.2023.02.028
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

889-901

Informations de copyright

Copyright © 2023 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Auteurs

Catherine S Giess (CS)

Deputy Chair of Radiology, Center for Evidence Based Imaging, and Department of Radiology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: cgiess@bwh.harvard.edu.

Elyse Lynch (E)

Department of Radiology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts.

Ronilda Lacson (R)

Center for Evidence Based Imaging and Department of Radiology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts.

Neena Kapoor (N)

Center for Evidence Based Imaging and Department of Radiology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts; Associate Chair of Patient Experience, Department of Radiology, Mass General Brigham Health System, and Quality/Safety Officer for Brigham Radiology.

Sonali Desai (S)

Chief Quality Officer, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts.

Ramin Khorasani (R)

Vice Chair of Quality/Safety/Patient Experience for Mass General Brigham Health System, Center for Evidence Based Imaging and Department of Radiology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH